Seed startup

Who invested in Telo Therapeutics

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$4.7Mraised across 1 round since 2021, from 1 source

Latest round
Seed, $4.7MJun 2021
Investors
1
See who backed them

The rounds

  1. Jun 2021
    Seed$4.7M

    Source recordedSEC filing: $4.2M sold, first sale Jun 2021

Everyone who backed them

Mission BioCapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 3 firms list Telo Therapeutics as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Myeloma Investment FundCorporate VCPer its own site
Sontag Innovation FundInstitutional LPPer its own site
Brain Tumor Investment FundCorporate VCPer its own site

Quick answers about Telo Therapeutics

Who invested in Telo Therapeutics?

Telo Therapeutics's investors include Mission BioCapital.

How much has Telo Therapeutics raised?

Telo Therapeutics has raised $4.7M across 1 round since 2021.

When did Telo Therapeutics last raise?

Telo Therapeutics's most recent round was a Seed of $4.7M in Jun 2021.

What was Telo Therapeutics's biggest round?

Its most recent round, $4.7M in Jun 2021, is also its largest on record.

Who backed Telo Therapeutics first?

Telo Therapeutics's first round on record, in Jun 2021, was backed by Mission BioCapital.

What stage is Telo Therapeutics at?

Telo Therapeutics's latest named round is a Seed, in Jun 2021.

Companies like Telo Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.